Javascript must be enabled to continue!
Intermittent Subglottic Secretion Drainage and Ventilator-associated Pneumonia: A Multicenter Trial
View through CrossRef
Abstract
Rationale
Ventilator-associated pneumonia (VAP) causes substantial morbidity and mortality. The influence of subglottic secretion drainage (SSD) in preventing VAP remains controversial.
Objectives
To determine whether SSD reduces the overall incidence of microbiologically confirmed VAP.
Methods
Randomized controlled clinical trial conducted at four French centers. A total of 333 adult patients intubated with a tracheal tube allowing drainage of subglottic secretions and expected to require mechanical ventilation for ≥48 hours was included. Patients were randomly assigned to undergo intermittent SSD (n = 169) or not (n = 164).
Measurements and Main Results
Primary outcome was the overall incidence of VAP based on quantitative culture of distal pulmonary samplings performed after each clinical suspicion. Other outcomes included incidence of early- and late-onset VAP, duration of mechanical ventilation, and hospital mortality. Microbiologically confirmed VAP occurred in 67 patients, 25 of 169 (14.8%) in the SSD group and 42 of 164 (25.6%) in the control group (P = 0.02), yielding a relative risk reduction of 42.2% (95% confidential interval, 10.4–63.1%). Using the Day 5 threshold, the beneficial effect of SSD in reducing VAP was observed in both early-onset VAP (2 of 169 [1.2%] patients undergoing SSD vs. 10 of 164 [6.1%] control patients; P = 0.02) and late-onset VAP (23 of 126 [18.6%] patients undergoing SSD vs. 32 of 97 [33.0%] control patients; P = 0.01). VAP was clinically suspected at least once in 51 of 169 (30.2%) patients undergoing SSD and 60 of 164 (36.6%) control patients (P = 0.25). No significant between-group differences were observed in duration of mechanical ventilation and hospital mortality.
Conclusions
Subglottic secretion drainage during mechanical ventilation results in a significant reduction in VAP, including late-onset VAP.
Clinical trial registered with www.clinicaltrials.gov (NCT00219661).
Title: Intermittent Subglottic Secretion Drainage and Ventilator-associated Pneumonia: A Multicenter Trial
Description:
Abstract
Rationale
Ventilator-associated pneumonia (VAP) causes substantial morbidity and mortality.
The influence of subglottic secretion drainage (SSD) in preventing VAP remains controversial.
Objectives
To determine whether SSD reduces the overall incidence of microbiologically confirmed VAP.
Methods
Randomized controlled clinical trial conducted at four French centers.
A total of 333 adult patients intubated with a tracheal tube allowing drainage of subglottic secretions and expected to require mechanical ventilation for ≥48 hours was included.
Patients were randomly assigned to undergo intermittent SSD (n = 169) or not (n = 164).
Measurements and Main Results
Primary outcome was the overall incidence of VAP based on quantitative culture of distal pulmonary samplings performed after each clinical suspicion.
Other outcomes included incidence of early- and late-onset VAP, duration of mechanical ventilation, and hospital mortality.
Microbiologically confirmed VAP occurred in 67 patients, 25 of 169 (14.
8%) in the SSD group and 42 of 164 (25.
6%) in the control group (P = 0.
02), yielding a relative risk reduction of 42.
2% (95% confidential interval, 10.
4–63.
1%).
Using the Day 5 threshold, the beneficial effect of SSD in reducing VAP was observed in both early-onset VAP (2 of 169 [1.
2%] patients undergoing SSD vs.
10 of 164 [6.
1%] control patients; P = 0.
02) and late-onset VAP (23 of 126 [18.
6%] patients undergoing SSD vs.
32 of 97 [33.
0%] control patients; P = 0.
01).
VAP was clinically suspected at least once in 51 of 169 (30.
2%) patients undergoing SSD and 60 of 164 (36.
6%) control patients (P = 0.
25).
No significant between-group differences were observed in duration of mechanical ventilation and hospital mortality.
Conclusions
Subglottic secretion drainage during mechanical ventilation results in a significant reduction in VAP, including late-onset VAP.
Clinical trial registered with www.
clinicaltrials.
gov (NCT00219661).
Related Results
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
A Clinical Study of Ventilator Associated Pneumonia
A Clinical Study of Ventilator Associated Pneumonia
Background: Ventilator Associated Pneumonia is a significant cause of mortality and morbidity in the critical care setting. Ventilator Associated Pneumonias are highly preventable ...
PROBIOTICS FOR THE PREVENTION OF VENTILATOR-ASSOCIATED PNEUMONIA
PROBIOTICS FOR THE PREVENTION OF VENTILATOR-ASSOCIATED PNEUMONIA
Ventilator-associated pneumonia is associated with a high rate of all-cause mortality and a prolonged duration of mechanical ventilation and intensive care unit stay. Ventilator as...
BACTERIOLOGY AND ANTIBIOTIC SENSITIVITY PATTERNS IN VENTILATOR-ASSOCIATED PNEUMONIA
BACTERIOLOGY AND ANTIBIOTIC SENSITIVITY PATTERNS IN VENTILATOR-ASSOCIATED PNEUMONIA
Background: Ventilator-Associated Pneumonia is the most common cause of hospital-acquired infections among patients admitted in Intensive Care Unit with mechanical ventilation. Ide...
Subglottic Stenosis in a 3-Year-Old Child Following Prolonged Intubation - A Case Report
Subglottic Stenosis in a 3-Year-Old Child Following Prolonged Intubation - A Case Report
Subglottic stenosis is a serious complication of prolonged intubation in pediatric patients and Over 90% of acquired cases are iatrogenically caused and result from endotracheal in...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Intermittent CSF drainage and rapid EVD weaning approach after subarachnoid hemorrhage: association with fewer VP shunts and shorter length of stay
Intermittent CSF drainage and rapid EVD weaning approach after subarachnoid hemorrhage: association with fewer VP shunts and shorter length of stay
OBJECTIVEThere is variability and uncertainty about the optimal approach to the management and discontinuation of an external ventricular drain (EVD) after subarachnoid hemorrhage ...

